CARDIOPROTECTIVE ACTIVITY OF EMPAGLIFLOZIN AND LIRAGLUTIDE WITH OR WITHOUT METFORMIN IN DIABETIC RATS INDUCED BY ACUTE MYOCARDIAL INFARCTION
DM patients with comorbid cardiovascular disease are recommended to use sodium glucose cotransporter-2 inhibitors (SGLT2i) and glucagon like Peptide 1 receptor agonist (GLP1-RA) which have been proven to reduce the risk of complications of myocardial infarction. In addition, metformin is also th...
Saved in:
Main Author: | Sukaeningsih, Desi |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/78113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
CARDIOPROTECTIVE ACTIVITY OF EMPAGLIFLOZIN AND LIRAGLUTIDE IN DIABETIC RATS INDUCED WITH ACUTE MYOCARDIAL INFARCTION
by: Fathadina, Almira -
CARDIOPROTECTIVE ACTIVITY OF EMPAGLIFLOZIN AND LINAGLIPTIN WITH OR WITHOUT METFORMIN IN DIABETIC RATS INDUCED WITH ACUTE MYOCARDIAL INFARCTION
by: Hasna Fadhilah, Zahra -
Mitochondria in acute myocardial infarction and cardioprotection
by: Ramachandra, C.J.A., et al.
Published: (2021) -
Cardioprotective effects of nitroparacetamol and paracetamol in acute phase of myocardial infarction in experimental rats
by: Zhu, Y.Z., et al.
Published: (2011) -
Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats
by: Ji, X., et al.
Published: (2012)